A FinnGen pilot clinical recall study for Alzheimer's disease
© 2023. Springer Nature Limited..
Successful development of novel therapies requires that clinical trials are conducted in patient cohorts with the highest benefit-to-risk ratio. Population-based biobanks with comprehensive health and genetic data from large numbers of individuals hold promise to facilitate identification of trial participants, particularly when interventions need to start while symptoms are still mild, such as for Alzheimer's disease (AD). This study describes a process for clinical recall studies from FinnGen. We demonstrate the feasibility to systematically ascertain customized clinical data from FinnGen participants with ICD10 diagnosis of AD or mild cognitive disorder (MCD) in a single-center cross-sectional study testing blood-based biomarkers and cognitive functioning in-person, computer-based and remote. As a result, 19% (27/140) of a pre-specified FinnGen subcohort were successfully recalled and completed the study. Hospital records largely validated registry entries. For 8/12 MCD patients, other reasons than AD were identified as underlying diagnosis. Cognitive measures correlated across platforms, with highest consistencies for dementia screening (r = 0.818) and semantic fluency (r = 0.764), respectively, for in-person versus telephone-administered tests. Glial fibrillary acidic protein (GFAP) (p < 0.002) and phosphorylated-tau 181 (pTau-181) (p < 0.020) most reliably differentiated AD from MCD participants. We conclude that informative, customized clinical recall studies from FinnGen are feasible.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:13 |
|---|---|
| Enthalten in: |
Scientific reports - 13(2023), 1 vom: 03. Aug., Seite 12641 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Julkunen, Valtteri [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Amyloid beta-Peptides |
|---|
| Anmerkungen: |
Date Completed 07.08.2023 Date Revised 18.11.2023 published: Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1038/s41598-023-39835-7 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM360369936 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM360369936 | ||
| 003 | DE-627 | ||
| 005 | 20231226210726.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1038/s41598-023-39835-7 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1201.xml |
| 035 | |a (DE-627)NLM360369936 | ||
| 035 | |a (NLM)37537264 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Julkunen, Valtteri |e verfasserin |4 aut | |
| 245 | 1 | 2 | |a A FinnGen pilot clinical recall study for Alzheimer's disease |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 07.08.2023 | ||
| 500 | |a Date Revised 18.11.2023 | ||
| 500 | |a published: Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2023. Springer Nature Limited. | ||
| 520 | |a Successful development of novel therapies requires that clinical trials are conducted in patient cohorts with the highest benefit-to-risk ratio. Population-based biobanks with comprehensive health and genetic data from large numbers of individuals hold promise to facilitate identification of trial participants, particularly when interventions need to start while symptoms are still mild, such as for Alzheimer's disease (AD). This study describes a process for clinical recall studies from FinnGen. We demonstrate the feasibility to systematically ascertain customized clinical data from FinnGen participants with ICD10 diagnosis of AD or mild cognitive disorder (MCD) in a single-center cross-sectional study testing blood-based biomarkers and cognitive functioning in-person, computer-based and remote. As a result, 19% (27/140) of a pre-specified FinnGen subcohort were successfully recalled and completed the study. Hospital records largely validated registry entries. For 8/12 MCD patients, other reasons than AD were identified as underlying diagnosis. Cognitive measures correlated across platforms, with highest consistencies for dementia screening (r = 0.818) and semantic fluency (r = 0.764), respectively, for in-person versus telephone-administered tests. Glial fibrillary acidic protein (GFAP) (p < 0.002) and phosphorylated-tau 181 (pTau-181) (p < 0.020) most reliably differentiated AD from MCD participants. We conclude that informative, customized clinical recall studies from FinnGen are feasible | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 7 | |a tau Proteins |2 NLM | |
| 650 | 7 | |a Biomarkers |2 NLM | |
| 650 | 7 | |a Amyloid beta-Peptides |2 NLM | |
| 700 | 1 | |a Schwarz, Claudia |e verfasserin |4 aut | |
| 700 | 1 | |a Kalapudas, Juho |e verfasserin |4 aut | |
| 700 | 1 | |a Hallikainen, Merja |e verfasserin |4 aut | |
| 700 | 1 | |a Piironen, Aino-Kaisa |e verfasserin |4 aut | |
| 700 | 1 | |a Mannermaa, Arto |e verfasserin |4 aut | |
| 700 | 1 | |a Kujala, Hanna |e verfasserin |4 aut | |
| 700 | 1 | |a Laitinen, Timo |e verfasserin |4 aut | |
| 700 | 1 | |a Kosma, Veli-Matti |e verfasserin |4 aut | |
| 700 | 1 | |a Paajanen, Teemu I |e verfasserin |4 aut | |
| 700 | 1 | |a Kälviäinen, Reetta |e verfasserin |4 aut | |
| 700 | 1 | |a Hiltunen, Mikko |e verfasserin |4 aut | |
| 700 | 1 | |a Herukka, Sanna-Kaisa |e verfasserin |4 aut | |
| 700 | 1 | |a Kärkkäinen, Sari |e verfasserin |4 aut | |
| 700 | 1 | |a Kokkola, Tarja |e verfasserin |4 aut | |
| 700 | 1 | |a Urjansson, Mia |e verfasserin |4 aut | |
| 700 | 0 | |a FinnGen |e verfasserin |4 aut | |
| 700 | 1 | |a Perola, Markus |e verfasserin |4 aut | |
| 700 | 1 | |a Palotie, Aarno |e verfasserin |4 aut | |
| 700 | 1 | |a Vuoksimaa, Eero |e verfasserin |4 aut | |
| 700 | 1 | |a Runz, Heiko |e verfasserin |4 aut | |
| 700 | 1 | |a Soininen, Hilkka |e investigator |4 oth | |
| 700 | 1 | |a Heikkinen, Sami |e investigator |4 oth | |
| 700 | 1 | |a Mäkelä, Tomi P |e investigator |4 oth | |
| 700 | 1 | |a Kytölä, Anastasia |e investigator |4 oth | |
| 700 | 1 | |a Ganna, Andrea |e investigator |4 oth | |
| 700 | 1 | |a Jalanko, Anu |e investigator |4 oth | |
| 700 | 1 | |a Liu, Aoxing |e investigator |4 oth | |
| 700 | 1 | |a Lehisto, Arto |e investigator |4 oth | |
| 700 | 1 | |a Ghazal, Awaisa |e investigator |4 oth | |
| 700 | 1 | |a Kilpeläinen, Elina |e investigator |4 oth | |
| 700 | 1 | |a Widen, Elisabeth |e investigator |4 oth | |
| 700 | 1 | |a Saarentaus, Elmo |e investigator |4 oth | |
| 700 | 1 | |a Pitkänen, Esa |e investigator |4 oth | |
| 700 | 1 | |a Ollila, Hanna |e investigator |4 oth | |
| 700 | 1 | |a Laivuori, Hannele |e investigator |4 oth | |
| 700 | 1 | |a Heyne, Henrike |e investigator |4 oth | |
| 700 | 1 | |a Shen, Huei-Yi |e investigator |4 oth | |
| 700 | 1 | |a Rämö, Joel |e investigator |4 oth | |
| 700 | 1 | |a Karjalainen, Juha |e investigator |4 oth | |
| 700 | 1 | |a Mehtonen, Juha |e investigator |4 oth | |
| 700 | 1 | |a Pitkänen, Jyrki |e investigator |4 oth | |
| 700 | 1 | |a Pärn, Kalle |e investigator |4 oth | |
| 700 | 1 | |a Kivinen, Katja |e investigator |4 oth | |
| 700 | 1 | |a Lahtela, Elisa L |e investigator |4 oth | |
| 700 | 1 | |a Niemi, Mari E |e investigator |4 oth | |
| 700 | 1 | |a Kaunisto, Mari |e investigator |4 oth | |
| 700 | 1 | |a Kals, Mart |e investigator |4 oth | |
| 700 | 1 | |a Reeve, Mary Pat |e investigator |4 oth | |
| 700 | 1 | |a Aavikko, Mervi |e investigator |4 oth | |
| 700 | 1 | |a Mars, Nina |e investigator |4 oth | |
| 700 | 1 | |a Dada, Oluwaseun Alexander |e investigator |4 oth | |
| 700 | 1 | |a Parolo, Pietro Della Briotta |e investigator |4 oth | |
| 700 | 1 | |a Palta, Priit |e investigator |4 oth | |
| 700 | 1 | |a Weldatsadik, Rigbe |e investigator |4 oth | |
| 700 | 1 | |a Kajanne, Risto |e investigator |4 oth | |
| 700 | 1 | |a Rodosthenous, Rodos |e investigator |4 oth | |
| 700 | 1 | |a Ripatti, Samuli |e investigator |4 oth | |
| 700 | 1 | |a Ruotsalainen, Sanni |e investigator |4 oth | |
| 700 | 1 | |a Strausz, Satu |e investigator |4 oth | |
| 700 | 1 | |a Hassan, Shabbeer |e investigator |4 oth | |
| 700 | 1 | |a Padmanabhuni, Shanmukha Sampath |e investigator |4 oth | |
| 700 | 1 | |a Luo, Shuang |e investigator |4 oth | |
| 700 | 1 | |a Lemmelä, Susanna |e investigator |4 oth | |
| 700 | 1 | |a Tukiainen, Taru |e investigator |4 oth | |
| 700 | 1 | |a Sipilä, Timo P |e investigator |4 oth | |
| 700 | 1 | |a Kiiskinen, Tuomo |e investigator |4 oth | |
| 700 | 1 | |a Llorens, Vincent |e investigator |4 oth | |
| 700 | 1 | |a Partanen, Juulia |e investigator |4 oth | |
| 700 | 1 | |a Havulinna, Aki |e investigator |4 oth | |
| 700 | 1 | |a Lee, Jiwoo |e investigator |4 oth | |
| 700 | 1 | |a Tsuo, Kristin |e investigator |4 oth | |
| 700 | 1 | |a Kurki, Mitja |e investigator |4 oth | |
| 700 | 1 | |a Vaura, Felix |e investigator |4 oth | |
| 700 | 1 | |a Suvisaari, Jaana |e investigator |4 oth | |
| 700 | 1 | |a Niiranen, Teemu |e investigator |4 oth | |
| 700 | 1 | |a Salomaa, Veikko |e investigator |4 oth | |
| 700 | 1 | |a Chen, Chia-Yen |e investigator |4 oth | |
| 700 | 1 | |a John, Sally |e investigator |4 oth | |
| 700 | 1 | |a Lahdenperä, Sanni |e investigator |4 oth | |
| 700 | 1 | |a Loomis, Stephanie |e investigator |4 oth | |
| 700 | 1 | |a Eaton, Susan |e investigator |4 oth | |
| 700 | 1 | |a Ziemann, Adam |e investigator |4 oth | |
| 700 | 1 | |a Abbasi, Ali |e investigator |4 oth | |
| 700 | 1 | |a Lehtonen, Anne |e investigator |4 oth | |
| 700 | 1 | |a Lertratanakul, Apinya |e investigator |4 oth | |
| 700 | 1 | |a Riley-Gillis, Bridget |e investigator |4 oth | |
| 700 | 1 | |a Rahimov, Fedik |e investigator |4 oth | |
| 700 | 1 | |a Jacob, Howard |e investigator |4 oth | |
| 700 | 1 | |a Waring, Jeffrey |e investigator |4 oth | |
| 700 | 1 | |a Liu, Mengzhen |e investigator |4 oth | |
| 700 | 1 | |a Smaoui, Nizar |e investigator |4 oth | |
| 700 | 1 | |a Popovic, Relja |e investigator |4 oth | |
| 700 | 1 | |a Matakidou, Athena |e investigator |4 oth | |
| 700 | 1 | |a Challis, Benjamin |e investigator |4 oth | |
| 700 | 1 | |a Paul, Dirk |e investigator |4 oth | |
| 700 | 1 | |a Lassi, Glenda |e investigator |4 oth | |
| 700 | 1 | |a Tachmazidou, Ioanna |e investigator |4 oth | |
| 700 | 1 | |a Platt, Adam |e investigator |4 oth | |
| 700 | 1 | |a Okafo, George |e investigator |4 oth | |
| 700 | 1 | |a Salminen-Mankonen, Heli |e investigator |4 oth | |
| 700 | 1 | |a Jung, Marc |e investigator |4 oth | |
| 700 | 1 | |a Lawless, Nathan |e investigator |4 oth | |
| 700 | 1 | |a Ding, Zhihao |e investigator |4 oth | |
| 700 | 1 | |a Maranville, Joseph |e investigator |4 oth | |
| 700 | 1 | |a Hochfeld, Marla |e investigator |4 oth | |
| 700 | 1 | |a Plenge, Robert |e investigator |4 oth | |
| 700 | 1 | |a Biswas, Shameek |e investigator |4 oth | |
| 700 | 1 | |a Choy, David |e investigator |4 oth | |
| 700 | 1 | |a Teng, Edmond |e investigator |4 oth | |
| 700 | 1 | |a Strauss, Erich |e investigator |4 oth | |
| 700 | 1 | |a Chen, Hao |e investigator |4 oth | |
| 700 | 1 | |a Chen, Hubert |e investigator |4 oth | |
| 700 | 1 | |a Schutzman, Jennifer |e investigator |4 oth | |
| 700 | 1 | |a Hunkapiller, Julie |e investigator |4 oth | |
| 700 | 1 | |a McCarthy, Mark |e investigator |4 oth | |
| 700 | 1 | |a Bowers, Natalie |e investigator |4 oth | |
| 700 | 1 | |a Pendergrass, Rion |e investigator |4 oth | |
| 700 | 1 | |a Lu, Tim |e investigator |4 oth | |
| 700 | 1 | |a Kumar, Janet |e investigator |4 oth | |
| 700 | 1 | |a Ehm, Margaret G |e investigator |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |t Scientific reports |d 2011 |g 13(2023), 1 vom: 03. Aug., Seite 12641 |w (DE-627)NLM215703936 |x 2045-2322 |7 nnns |
| 773 | 1 | 8 | |g volume:13 |g year:2023 |g number:1 |g day:03 |g month:08 |g pages:12641 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1038/s41598-023-39835-7 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 13 |j 2023 |e 1 |b 03 |c 08 |h 12641 | ||